PAR 3.57% 27.0¢ paradigm biopharmaceuticals limited..

The competition and their side effects, page-18

  1. 2,112 Posts.
    lightbulb Created with Sketch. 68
    Probably have seen this from Aunty, but may be part of reason for greater interest in PAR....

    OxyContin maker Purdue Pharma reaches $270 million settlement over opioid crisis
    Updated about 2 hours ago
    Space to play or pause, M to mute, left and right arrows to seek, up and down arrows for volume.
    VIDEO: Purdue Pharma denied any wrongdoing but agreed to a settlement. (ABC News)

    RELATED STORY: 'They should be in jail with El Chapo': Gallery rejects donation from family linked to opioid crisis
    RELATED STORY: The small-town doctor taking on the billionaire family blamed for America's opioid crisis
    RELATED STORY: Why people use painkillers for emotional relief

    OxyContin maker Purdue Pharma LP and members of the wealthy Sackler family that own the company have reached a $US270 million ($378 million) settlement to resolve a lawsuit accusing the drugmaker of fuelling an opioid abuse epidemic.
    Key points:
    • Oklahoma's Attorney-General accused Purdue Pharma of downplaying opioid addiction risks
    • Purdue's legal team argued labels featured a warning about the risk of opioid abuse and misuse
    • The lawsuit was due to go to a trial before a jury in May
    The settlement in the case, which was brought by the US state of Oklahoma, was unveiled by Attorney-General Mike Hunter on Tuesday.
    It was the first to result from a wave of recent lawsuits accusing Purdue of deceptively marketing painkillers, helping create a deadly crisis sweeping the US.
    Mr Hunter's 2017 lawsuit was set to go to a jury on May 28 in what would have been the first trial to result from roughly 2,000 lawsuits filed in federal and state courts nationwide against Purdue and other drugmakers.
    Mr Hunter alleged Purdue, Johnson & Johnson and Teva Pharmaceutical Industries Ltd engaged in deceptive marketing that played down the risks of addiction associated with opioids while overstating their benefits, contributing to the epidemic.
    Opioids, including prescription painkillers, heroin and fentanyl, were involved in a record 47,600 overdose deaths in 2017 in the US, according to the US Centres for Disease Control and Prevention.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
27.0¢
Change
-0.010(3.57%)
Mkt cap ! $82.30M
Open High Low Value Volume
28.0¢ 28.0¢ 26.5¢ $281.4K 1.024M

Buyers (Bids)

No. Vol. Price($)
1 3499 27.0¢
 

Sellers (Offers)

Price($) Vol. No.
28.0¢ 161588 8
View Market Depth
Last trade - 16.10pm 21/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.